| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 90586 |
5-乙烯基-2-降冰片烯(VNB) |
909 |
h |
2024-11-29 |
| 90587 |
2-乙烯基-5-降冰片烯(VNB) |
295 |
h |
2024-11-29 |
| 90588 |
94885-04-8，C6NBD-神经鞘氨酯，C6 NBD Sphingomyelin (d18:1/6:0) |
151 |
kx |
2024-11-29 |
| 90589 |
降冰片烯二酸酐(XMNA) |
327 |
h |
2024-11-29 |
| 90590 |
5-降冰片烯-2,3-二羧酸二甲酯(DCNM) |
183 |
h |
2024-11-29 |
| 90591 |
5-降冰片烯-2-亚甲基-(6-溴己基)醚(NB-O-Br) |
210 |
h |
2024-11-29 |
| 90592 |
N-环庚基降冰片烯酰亚胺(CHepNDI) |
156 |
h |
2024-11-29 |
| 90593 |
5-降冰片烯-2-甲醇(NB-CH2OH) |
198 |
h |
2024-11-29 |
| 90594 |
Tz-BODIPY-MOR；氟化硼二吡咯-四嗪靶向溶酶体 |
204 |
|
2024-11-29 |
| 90595 |
5-降冰片烯-2-甲醛 |
184 |
h |
2024-11-29 |
| 90596 |
侧链双键的降冰片烯衍生物(ENB) |
322 |
h |
2024-11-29 |
| 90597 |
降冰片烯基三氟乙酯(NF) |
288 |
h |
2024-11-29 |
| 90598 |
2375774-54-0，Pomalidomide-C6-O-C5-O-C4-COOH |
180 |
kx |
2024-11-29 |
| 90599 |
3,6-二-2-吡啶基-1,2,4,5-四嗪 |
175 |
WYQ |
2024-11-29 |
| 90600 |
钯芳基降冰片烯五元环(ANP) |
217 |
h |
2024-11-29 |
| 90601 |
（2-氨基乙基）-吗啉基团偶联3-（吡啶-3-基）-6-氨基乙基-1,2,4,5-四嗪偶联（LysoTz） |
175 |
WYQ |
2024-11-29 |
| 90602 |
降冰片烯羧酸甲酯聚合物(P(exo-MeNB) |
146 |
h |
2024-11-29 |
| 90603 |
1578249-76-9，Mal-C6-α-Amanitin |
133 |
kx |
2024-11-29 |
| 90604 |
降冰片烯二酸酐-马来酰亚胺基七异丁基聚倍半硅氧烷交替共聚物 poly(MIPOSS-alt-NA) |
367 |
h |
2024-11-29 |
| 90605 |
5-丁氧基亚甲基-2-降冰片烯,双-(β-酮萘胺)镍(Ⅱ)/B(C6F5)3 |
189 |
h |
2024-11-29 |
| 90606 |
CAS:2921619-48-7；DOTA-方酸-PEG4(丙酸)-ONCOFAP |
283 |
zcy |
2024-11-29 |
| 90607 |
萘酰亚胺修饰聚降冰片烯共聚物P-NB-NA-PEG |
142 |
h |
2024-11-29 |
| 90608 |
聚乙叉降冰片烯二乙烯基联苯共聚物 |
225 |
h |
2024-11-29 |
| 90609 |
ROPARGYL-DOTA-TRIS(TBU)ESTER；基于NOTADOTA定制和偶联 |
194 |
zcy |
2024-11-29 |
| 90610 |
降冰片烯官能化聚丙烯酸叔丁酯(NB-PtBA) |
225 |
h |
2024-11-29 |
| 90611 |
聚降冰片烯纳米纤维(PNB) |
335 |
h |
2024-11-29 |
| 90612 |
TRI-TERT-BUTYL 1,4,7,10-TETRAAZACYCLODOD；三叔丁基-1,4,7,10-四氮杂环十二烷 |
191 |
zcy |
2024-11-29 |
| 90613 |
DOTA-3-酪氨酰基-奥曲肽（DOTA-3-Tyr-Octreotide） |
123 |
zcy |
2024-11-29 |
| 90614 |
94885-02-6， C6 NBD Ceramide |
203 |
kx |
2024-11-29 |
| 90615 |
DOTA-tris(TBE)-amido dPEG (R)11-Maleimide；基于NOTADOTA定制和偶联 |
203 |
zcy |
2024-11-29 |
| 90616 |
479081-06-6 , DOTA-(COOt-Bu)3-NHFmoc-Lys |
242 |
wyh |
2024-11-29 |
| 90617 |
DOTA-octreotide |
187 |
wyh |
2024-11-29 |
| 90618 |
CAS:127985-74-4 ，DOTA-p-NCS-Bn ，多肽标记的双功能螯合剂 |
304 |
wyh |
2024-11-29 |
| 90619 |
N-(2-溴代异丁酰溴基)-顺-5-降冰片烯-外-2,3-二甲酰亚胺(exo-BNDI) |
218 |
h |
2024-11-29 |
| 90620 |
cyclo(RGDFK(DOTA)) |
181 |
wyh |
2024-11-29 |
| 90621 |
DOTA-tris(acid)-amido-dPEG (R)24-amido-dPEG (R)24-DSPE 定制 |
201 |
zcy |
2024-11-29 |
| 90622 |
Lu-DOTA-TATE ；镥-大环配体-TATE多肽 |
214 |
wyh |
2024-11-29 |
| 90623 |
11,12-二脱氢-ε-氧代二苯并[b,f]氮杂环辛-5(6H)-己酸，DBCO-C6-acid |
175 |
kx |
2024-11-29 |
| 90624 |
降冰片烯改性聚乙烯醇(PVA) |
266 |
h |
2024-11-29 |
| 90625 |
DOTA-PEG-CPP ， DOTA-聚乙二醇-酪蛋白磷酸肽 |
258 |
wyh |
2024-11-29 |
| 90626 |
乙酰基保护的降冰片烯含异类糖单体NBManGluOAc |
180 |
h |
2024-11-29 |
| 90627 |
降冰片二烯二酸单甲酯(NBD-COOH) |
432 |
h |
2024-11-29 |
| 90628 |
DOTA-E「cyclo(RGDfK)2的结构组成 |
244 |
wyh |
2024-11-29 |
| 90629 |
Ho-p-SCN-Bn-DOTA；2126179-28-8；基于NOTADOTA定制和偶联 |
135 |
zcy |
2024-11-29 |
| 90630 |
十八烷基-聚乙二醇-巯基吡啶 OPSS-PEG-C18 |
142 |
zyl |
2024-11-29 |
齐岳微信公众号
官方微信
库存查询